Mark Forman

Mark Forman is the current Chief Medical Officer at Passage Bio. Mark has held previous positions as Senior Director of Drug Development at the Alzheimer's Drug Discovery Foundation, Vice President Translational Medicine at ACADIA Pharmaceuticals Inc., Executive Director at Merck, and Assistant Professor at the University of Pennsylvania. Mark has also been a Research Associate and Fellow at the University of Pennsylvania School of Medicine and the University of Pennsylvania Health System.

Mark Forman earned their MD from Duke University School of Medicine, their PhD in Immunology from The Rockefeller University, and their BS in Biochemistry and Molecular Biology from Yale University.

Their manager is Bruce A. Goldsmith, CEO. Some of their coworkers include Steve Biroc - VP of Project Management, Gary Romano - Chief Medical Officer, and Erin Brubaker - VP of Corporate Development. Some direct reports include D. Elizabeth Mcneil - Vice President, Clinical Development, A.J. Mayorga - Vice President, Clinical Development, and Michele Clarke - Vice President, Patient Engagement.